Regulatory best practices for global access to medicines, including TB medicines

The U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) will conduct a three half-days conference Regulatory Best Practices for Global Access to Medicines, Including Anti-TB Medicines on 16-18 August 2022.